Wednesday, July 8, 2026
🇺🇸 FDA

pharma · HIV Infections · Major Depressive Disorder · PRAX

Praxis Precision Medicines

Praxis Precision Medicines patent portfolio — 35 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Boston, USA HQ
205 Employees
Public company Type
PRAX · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Employees
205
Programs
7
Drugs
8
Patents
35
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Praxis Precision Medicines patents

35 pharmaceutical patents indexed for Praxis Precision Medicines. 0 expire within 24 months.

Praxis Precision Medicines has 35 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

35 patents

Patent portfolio

  1. US 12404297

    Salts and crystal forms of GABA-A positive allosteric modulator

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12325711

    3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12259378

    Dynamic clamps and methods of use thereof

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12145939

    Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12077502

    Formulations of T-type calcium channel modulators and methods of use thereof

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11919836

    Prodrugs of fencamfamine

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11918571

    Compounds and their methods of use

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11866439

    Ion channel modulators

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11780821

    Inhibitors of fibroblast activation protein

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11767325

    Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11731978

    3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11731976

    3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11731966

    Compounds and their methods of use

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11697669

    Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereof

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11649207

    Formulations of T-type calcium channel modulators and methods of use thereof

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11629146

    Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11504364

    Inhibitors of fibroblast activation protein

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11492345

    Compounds and their methods of use

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11427540

    Formulations of T-type calcium channel modulators and methods of use thereof

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11318133

    Modulators of integrated stress response pathway

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11278535

    Compounds and their methods of use

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11261188

    Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11230542

    Inhibitors of integrated stress response pathway

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11166942

    Inhibitors of integrated stress response pathway

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11014931

    3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10927141

    Salts and crystal forms of GABAA positive allosteric modulator

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10662146

    Prodrugs of fencamfamine

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10562930

    Salts and crystal forms of GABAA positive allosteric modulator

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10206886

    Lipid nanoparticles for wound healing

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9200077

    Injectable solution containing therapeutic agent for osteoarthritis

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8784802

    Ischemic tissue cell therapy

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8729027

    Therapeutic agent for fibromyalgia containing etanercept

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8377444

    Therapeutic agent or preventive agent for osteoarthritis

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 6420134

    Vaccines for nontypable haemophilus influenzae

    Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6296607

    In situ bulking device

    Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Praxis Precision Medicines have?

35 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Praxis Precision Medicines patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.